These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35158001)

  • 1. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.
    Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF
    J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hyperpigmentation in darker racial ethnic groups.
    Grimes PE
    Semin Cutan Med Surg; 2009 Jun; 28(2):77-85. PubMed ID: 19608057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Insights in Melasma and Hyperpigmentation Management.
    Huerth KA; Hassan S; Callender VD
    J Drugs Dermatol; 2019 Aug; 18(8):718-729. PubMed ID: 31424704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postinflammatory hyperpigmentation: A comprehensive overview: Treatment options and prevention.
    Chaowattanapanit S; Silpa-Archa N; Kohli I; Lim HW; Hamzavi I
    J Am Acad Dermatol; 2017 Oct; 77(4):607-621. PubMed ID: 28917452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of melasma treatment focusing on laser and light devices.
    Li JY; Geddes ER; Robinson DM; Friedman PM
    Semin Cutan Med Surg; 2016 Dec; 35(4):223-232. PubMed ID: 27918005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melasma and Post Inflammatory Hyperpigmentation: Management Update and Expert Opinion.
    Sofen B; Prado G; Emer J
    Skin Therapy Lett; 2016 Jan; 21(1):1-7. PubMed ID: 27224897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
    Spierings NMK
    J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 1064 nm Q-switched Nd:YAG laser and Jessner peeling in melasma treatment.
    Ertam Sagduyu I; Marakli O; Oraloglu G; Bulut Okut E; Unal I
    Dermatol Ther; 2022 Dec; 35(12):e15970. PubMed ID: 36346028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of laser and light therapy in melasma.
    Trivedi MK; Yang FC; Cho BK
    Int J Womens Dermatol; 2017 Mar; 3(1):11-20. PubMed ID: 28492049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's new in objective assessment and treatment of facial hyperpigmentation?
    Molinar VE; Taylor SC; Pandya AG
    Dermatol Clin; 2014 Apr; 32(2):123-35. PubMed ID: 24679999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melasma Treatment: An Evidence-Based Review.
    McKesey J; Tovar-Garza A; Pandya AG
    Am J Clin Dermatol; 2020 Apr; 21(2):173-225. PubMed ID: 31802394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of energy-based devices combination therapy for melasma.
    Iranmanesh B; Khalili M; Mohammadi S; Amiri R; Aflatoonian M
    Dermatol Ther; 2021 May; 34(3):e14927. PubMed ID: 33665885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New horizons in treating disorders of hyperpigmentation in skin of color.
    Konda S; Geria AN; Halder RM
    Semin Cutan Med Surg; 2012 Jun; 31(2):133-9. PubMed ID: 22640434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Update on New and Existing Treatments for the Management of Melasma.
    Gan C; Rodrigues M
    Am J Clin Dermatol; 2024 Sep; 25(5):717-733. PubMed ID: 38896402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperpigmentation and melasma.
    Rigopoulos D; Gregoriou S; Katsambas A
    J Cosmet Dermatol; 2007 Sep; 6(3):195-202. PubMed ID: 17760699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemical peeling for treatment of Melasma, pigmentary disorders and hyperpigmentation : Indications, effectivity and risks].
    Borelli C; Fischer S
    Hautarzt; 2020 Dec; 71(12):950-959. PubMed ID: 33141276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New and experimental treatments of cloasma and other hypermelanoses.
    Picardo M; Carrera M
    Dermatol Clin; 2007 Jul; 25(3):353-62, ix. PubMed ID: 17662901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Safety and Efficacy of Treatment With a 1,927-nm Diode Laser With and Without Topical Hydroquinone for Facial Hyperpigmentation and Melasma in Darker Skin Types.
    Vanaman Wilson MJ; Jones IT; Bolton J; Larsen L; Fabi SG
    Dermatol Surg; 2018 Oct; 44(10):1304-1310. PubMed ID: 29659405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional 1064 nm Picosecond Laser in Treatment of Melasma and Skin Rejuvenation in Asians, A Prospective Study.
    Wong CSM; Chan MWM; Shek SYN; Yeung CK; Chan HHL
    Lasers Surg Med; 2021 Oct; 53(8):1032-1042. PubMed ID: 33544930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.